Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Low or high magnesium concentration in intermittent warm blood cardioplegia in patients undergoing coronary artery surgery: a prospective randomised study
Source of recordUK Trials
ISRCTNISRCTN95530505
Date ISRCTN assigned23/04/2002
Local reference number(s)PG/02/044/13713
Public titleLow or high magnesium concentration in intermittent warm blood cardioplegia in patients undergoing coronary artery surgery: a prospective randomised study
Scientific title
AcronymN/A
Disease/condition/study domainIschaemic heart disease
Study hypothesisA comparison between two diferent strategies of myocardial protection.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. A diagnosis of ischaemic heart disease
2. Undergoing primary myocardial revascularisation with the use of cardiopulmonary bypass and cardioplegic arrest
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/12/2001
Anticipated end date01/12/2004
Status of trialCompleted
Target number of participants400 adult patients
InterventionsPatients will be randomised to:
1. 5 mmol/l Magnesium (Mg2+)
2. 16 mmol/l Mg2+)
In the intermittent antegrade warm blood cardioplegia
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingBritish Heart Foundation (UK)
Sponsor nameBritish Heart Foundation (UK)
Sponsor details14 Fitzhardinge Street
London
United Kingdom
W1H 6DH
Sponsor telephone+44 (0)20 7935 0185
Sponsor fax+44 (0)20 7486 5820
Sponsor emailresearch@bhf.org.uk
Sponsor websitehttp://www.bhf.org.uk/
Contact nameMr Massimo Caputo
Contact detailsBristol Heart Institute
Bristol Royal Infirmary
Marlborough Street
Bristol
United Kingdom
BS2 8HW
Contact telephone+44 (0)117 9283145
Contact fax+44 (0)117 929737
Contact emailmassimocaputo@hotmail.com
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN95530505
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central